The new defi nition and diagnostic criteria of Parkinson's disease
We thank The Lancet Neurology for highlighting the changes in Parkinson's disease diagnosis given in the new International Parkinson Disease and Movement Disorder Society diagnostic criteria. 1 The criteria were created in response to the huge advances in our understanding of Parkinson's disease over the past 20 years, especially the identifi cation of α-synuclein, advances in genetics, recognition of non-motor Parkinson's disease, and the realisation that prodromal stages exist. The Movement Disorder Society recognised that these advances challenge the fundamental defi nition of Parkinson's disease and created a task force to examine potential changes to the Parkinson's disease defi nition, 1 develop revised diagnostic criteria, 2 and develop research criteria for prodromal Parkinson's disease. 3 The fi nal task force reports were recently published. 2, 3 But, what has changed and what remains the same?
Several key defi nition decisions were made. 4 Parkinson's disease was defi ned as a synucleinopathy. Despite numerous challenges (rare genetic forms without synuclein deposition, synuclein deposition possibly occurring later than other changes, or inability to document deposition during life), synuclein deposition remains the main fi nal arbiter of diagnosis. However, *Ronald B Postuma †, Daniela Berg †, Charles H Adler, Bastiaan R Bloem, Piu Chan, Günther Deuschl, Thomas Gasser, Christopher G Goetz, Glenda Halliday, Lawrence Joseph, Anthony E Lang , Inga Liepelt-Scarfone, Irene Litvan, Kenneth Marek, Wolfgang Oertel, C Warren Olanow, Werner Poewe, Matthew Stern 
